Benitec Biopharma (BNTC) Asset Utilization Ratio (2020 - 2024)

Benitec Biopharma has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.0 in Q1 2024.

• Quarterly Asset Utilization Ratio fell 94.3% year-over-year to 0.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.0 (down 94.3% YoY) and the FY2023 annual result came in at 0.01, up 169.25% from the prior year.
• Asset Utilization Ratio retreated to 0.0 in Q1 2024 per BNTC's latest filing, from 0.0 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.01 in Q3 2020 and troughed at 0.0 in Q3 2021.
• A 5-year average of 0.0 and a median of 0.0 in 2022 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio tumbled 98.33% in 2021, then surged 2871.08% in 2022.
• Over 5 years, Asset Utilization Ratio stood at 0.0 in 2020, then plunged by 56.17% to 0.0 in 2021, then soared by 134.93% to 0.0 in 2022, then tumbled by 38.98% to 0.0 in 2023, then tumbled by 84.72% to 0.0 in 2024.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.0, 0.0, and 0.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.